Lower Drug Costs Claims
Just how how large is the difference between drug prices in the U.S. and Europe?
Read the post
Lower Drug Costs Stakeholders
What do stakeholders have to say about the Lower Drug Costs Now Act of 2019?
Read the post
Lower Drug Prices Overview
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), is a bill before the House that is intended to make prescription drugs more affordable for those in the Medicare program. The bill also seeks to maintain Medicare's future viability.
Read the post
No-Deal Brexit UK Pharma
It’s become increasingly clear that the life science sector faces acute disruption as a result of this period of uncertainty, whether or not a satisfactory Brexit deal is ultimately reached.
Read the post
Implications of Pharma Outcomes
Oklahoma was the first state to file suit against opioid manufacturers. The success of their legal strategy will have a significant impact on the opioid–and pharmaceutical–industry going forward.
Read the post
Asthma Biologics
Although asthma is a common chronic disease, there is currently no cure for it. Currently, physicians use a variety of means to reduce inflammation and keep it at bay. The extent of their success depends upon environmental factors, patient compliance and the “fit” of the treatment.
Read the post